Rosh Kumar Viasha Sethi, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head and Neck Neoplasms | 19 | 2024 | 2734 | 1.750 |
Why?
|
| Hospital Costs | 4 | 2019 | 985 | 1.070 |
Why?
|
| Laryngectomy | 5 | 2020 | 248 | 1.060 |
Why?
|
| Neck Injuries | 2 | 2019 | 152 | 1.040 |
Why?
|
| Rhinoplasty | 2 | 2019 | 226 | 1.040 |
Why?
|
| Parotid Gland | 3 | 2024 | 168 | 0.980 |
Why?
|
| Emergency Service, Hospital | 12 | 2020 | 7659 | 0.940 |
Why?
|
| Otolaryngology | 8 | 2018 | 645 | 0.900 |
Why?
|
| Adenoidectomy | 1 | 2022 | 159 | 0.770 |
Why?
|
| Sarcoma, Kaposi | 1 | 2024 | 370 | 0.760 |
Why?
|
| Pain, Postoperative | 3 | 2019 | 1643 | 0.730 |
Why?
|
| Oropharyngeal Neoplasms | 2 | 2023 | 477 | 0.690 |
Why?
|
| Analgesics, Opioid | 4 | 2019 | 3674 | 0.680 |
Why?
|
| Surgical Flaps | 8 | 2023 | 1640 | 0.670 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2020 | 118 | 0.670 |
Why?
|
| Drug Prescriptions | 2 | 2018 | 1637 | 0.660 |
Why?
|
| Alphapapillomavirus | 1 | 2021 | 221 | 0.640 |
Why?
|
| Fractures, Closed | 1 | 2019 | 88 | 0.640 |
Why?
|
| Fractures, Open | 1 | 2019 | 101 | 0.620 |
Why?
|
| Papillomavirus Infections | 4 | 2023 | 1587 | 0.590 |
Why?
|
| Punctures | 2 | 2017 | 374 | 0.580 |
Why?
|
| Epistaxis | 1 | 2017 | 111 | 0.570 |
Why?
|
| Parotid Neoplasms | 1 | 2018 | 155 | 0.570 |
Why?
|
| Hemostatic Techniques | 1 | 2017 | 116 | 0.560 |
Why?
|
| Paranasal Sinuses | 1 | 2018 | 250 | 0.550 |
Why?
|
| Health Care Costs | 4 | 2023 | 3209 | 0.540 |
Why?
|
| Carcinoma, Squamous Cell | 7 | 2023 | 4034 | 0.520 |
Why?
|
| Economic Competition | 2 | 2014 | 214 | 0.500 |
Why?
|
| Laryngeal Diseases | 1 | 2017 | 241 | 0.490 |
Why?
|
| Hearing Loss, Sensorineural | 3 | 2018 | 770 | 0.490 |
Why?
|
| Free Tissue Flaps | 4 | 2024 | 328 | 0.490 |
Why?
|
| Voice | 1 | 2017 | 259 | 0.480 |
Why?
|
| Pharyngeal Neoplasms | 1 | 2014 | 117 | 0.480 |
Why?
|
| Laryngeal Neoplasms | 2 | 2015 | 512 | 0.470 |
Why?
|
| Larynx | 1 | 2019 | 494 | 0.470 |
Why?
|
| Larynx, Artificial | 1 | 2014 | 69 | 0.470 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2014 | 90 | 0.460 |
Why?
|
| Skin Neoplasms | 3 | 2024 | 5686 | 0.450 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2018 | 1107 | 0.440 |
Why?
|
| Carcinoma | 3 | 2014 | 2375 | 0.440 |
Why?
|
| Rhinitis | 2 | 2018 | 691 | 0.430 |
Why?
|
| Neurites | 1 | 2014 | 388 | 0.430 |
Why?
|
| Endoscopy | 2 | 2018 | 1785 | 0.410 |
Why?
|
| Trachea | 1 | 2017 | 1076 | 0.410 |
Why?
|
| Esophagus | 1 | 2017 | 1019 | 0.400 |
Why?
|
| Paraganglioma | 1 | 2013 | 143 | 0.400 |
Why?
|
| Retrospective Studies | 39 | 2024 | 77449 | 0.400 |
Why?
|
| Minocycline | 1 | 2012 | 163 | 0.400 |
Why?
|
| Models, Educational | 1 | 2014 | 377 | 0.390 |
Why?
|
| Hyperpigmentation | 1 | 2012 | 112 | 0.390 |
Why?
|
| Sinusitis | 2 | 2018 | 923 | 0.390 |
Why?
|
| Hospitals | 5 | 2023 | 3952 | 0.370 |
Why?
|
| SEER Program | 3 | 2020 | 1508 | 0.370 |
Why?
|
| Medicare | 4 | 2023 | 6566 | 0.370 |
Why?
|
| Craniocerebral Trauma | 1 | 2014 | 482 | 0.360 |
Why?
|
| United States | 31 | 2023 | 69872 | 0.350 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2013 | 298 | 0.350 |
Why?
|
| Neck Dissection | 3 | 2019 | 197 | 0.340 |
Why?
|
| Insurance Coverage | 5 | 2020 | 1901 | 0.340 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 3 | 2018 | 312 | 0.320 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 851 | 0.300 |
Why?
|
| Humans | 86 | 2024 | 744343 | 0.300 |
Why?
|
| Postoperative Complications | 6 | 2020 | 15295 | 0.300 |
Why?
|
| Cochlear Implantation | 2 | 2023 | 310 | 0.290 |
Why?
|
| Middle Aged | 46 | 2024 | 213383 | 0.290 |
Why?
|
| Aged | 38 | 2024 | 163280 | 0.290 |
Why?
|
| Hippocampus | 1 | 2019 | 3675 | 0.290 |
Why?
|
| Cochlear Implants | 2 | 2023 | 339 | 0.290 |
Why?
|
| Female | 62 | 2024 | 380194 | 0.290 |
Why?
|
| Otitis Media | 2 | 2019 | 277 | 0.280 |
Why?
|
| Inpatients | 1 | 2018 | 2518 | 0.280 |
Why?
|
| Pharyngectomy | 2 | 2017 | 45 | 0.280 |
Why?
|
| Head | 2 | 2023 | 880 | 0.270 |
Why?
|
| Male | 59 | 2024 | 350118 | 0.270 |
Why?
|
| Patient Protection and Affordable Care Act | 3 | 2020 | 1209 | 0.260 |
Why?
|
| Thyroid Nodule | 1 | 2012 | 750 | 0.260 |
Why?
|
| Internship and Residency | 5 | 2018 | 5788 | 0.260 |
Why?
|
| Glioma | 1 | 2019 | 3401 | 0.240 |
Why?
|
| Mouth Neoplasms | 2 | 2020 | 601 | 0.240 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2019 | 709 | 0.240 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2013 | 1186 | 0.230 |
Why?
|
| Hospitalization | 4 | 2020 | 10262 | 0.220 |
Why?
|
| Adult | 34 | 2023 | 214055 | 0.220 |
Why?
|
| Papillomaviridae | 4 | 2023 | 1119 | 0.220 |
Why?
|
| Osteoradionecrosis | 1 | 2022 | 49 | 0.220 |
Why?
|
| Emergency Medical Services | 1 | 2014 | 1917 | 0.210 |
Why?
|
| Adolescent | 20 | 2023 | 85781 | 0.210 |
Why?
|
| Healthcare Disparities | 1 | 2017 | 3158 | 0.200 |
Why?
|
| Middle Ear Ventilation | 1 | 2022 | 94 | 0.200 |
Why?
|
| Nasolacrimal Duct | 1 | 2022 | 74 | 0.200 |
Why?
|
| Medicare Part B | 1 | 2022 | 108 | 0.190 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2022 | 104 | 0.190 |
Why?
|
| Child | 16 | 2022 | 77709 | 0.190 |
Why?
|
| Young Adult | 16 | 2020 | 56430 | 0.190 |
Why?
|
| Child, Preschool | 13 | 2020 | 41006 | 0.190 |
Why?
|
| Surgical Stomas | 1 | 2020 | 43 | 0.190 |
Why?
|
| Massachusetts | 4 | 2019 | 8663 | 0.180 |
Why?
|
| Melanoma | 1 | 2018 | 5510 | 0.180 |
Why?
|
| Endovascular Procedures | 1 | 2013 | 1979 | 0.170 |
Why?
|
| Thyroid Neoplasms | 1 | 2012 | 2282 | 0.170 |
Why?
|
| Hyperacusis | 1 | 2019 | 31 | 0.170 |
Why?
|
| Cross-Sectional Studies | 8 | 2023 | 25043 | 0.170 |
Why?
|
| Preoperative Care | 2 | 2018 | 2250 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2018 | 20129 | 0.170 |
Why?
|
| Job Application | 1 | 2018 | 39 | 0.160 |
Why?
|
| Labyrinthitis | 1 | 2018 | 29 | 0.160 |
Why?
|
| Logistic Models | 7 | 2020 | 13408 | 0.160 |
Why?
|
| Mastoiditis | 1 | 2018 | 34 | 0.160 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2023 | 3022 | 0.160 |
Why?
|
| Salvage Therapy | 3 | 2021 | 1275 | 0.160 |
Why?
|
| Cohort Studies | 10 | 2024 | 40561 | 0.160 |
Why?
|
| Aged, 80 and over | 10 | 2021 | 57776 | 0.150 |
Why?
|
| Treatment Outcome | 17 | 2021 | 63114 | 0.150 |
Why?
|
| Brain Abscess | 1 | 2018 | 118 | 0.150 |
Why?
|
| HIV Infections | 1 | 2024 | 16718 | 0.150 |
Why?
|
| Cell Differentiation | 1 | 2014 | 11483 | 0.150 |
Why?
|
| Jugular Veins | 1 | 2018 | 204 | 0.150 |
Why?
|
| Ranula | 1 | 2017 | 11 | 0.150 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2019 | 230 | 0.150 |
Why?
|
| Audiometry | 1 | 2018 | 241 | 0.150 |
Why?
|
| Combined Modality Therapy | 4 | 2017 | 8642 | 0.140 |
Why?
|
| Meningitis | 1 | 2018 | 216 | 0.140 |
Why?
|
| Tinnitus | 1 | 2019 | 195 | 0.140 |
Why?
|
| Personnel Selection | 1 | 2018 | 189 | 0.140 |
Why?
|
| After-Hours Care | 1 | 2017 | 102 | 0.140 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2019 | 252 | 0.140 |
Why?
|
| Surgery, Plastic | 1 | 2023 | 624 | 0.140 |
Why?
|
| Neuroma, Acoustic | 1 | 2020 | 451 | 0.140 |
Why?
|
| Tracheostomy | 1 | 2020 | 401 | 0.140 |
Why?
|
| Neck | 1 | 2020 | 697 | 0.140 |
Why?
|
| Clavicle | 2 | 2015 | 209 | 0.130 |
Why?
|
| Device Approval | 1 | 2017 | 163 | 0.130 |
Why?
|
| Glossectomy | 1 | 2015 | 58 | 0.130 |
Why?
|
| Multivariate Analysis | 5 | 2018 | 12245 | 0.130 |
Why?
|
| Education, Medical, Graduate | 3 | 2017 | 2291 | 0.130 |
Why?
|
| Diagnostic Techniques, Otological | 1 | 2015 | 12 | 0.130 |
Why?
|
| Supratentorial Neoplasms | 2 | 2013 | 160 | 0.130 |
Why?
|
| Auditory Brain Stem Implants | 1 | 2014 | 30 | 0.130 |
Why?
|
| Acetaminophen | 1 | 2019 | 545 | 0.120 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2022 | 1018 | 0.120 |
Why?
|
| Facial Paralysis | 1 | 2018 | 338 | 0.120 |
Why?
|
| Speech Disorders | 1 | 2015 | 189 | 0.120 |
Why?
|
| Maxillary Sinus Neoplasms | 1 | 2014 | 40 | 0.120 |
Why?
|
| Area Under Curve | 1 | 2018 | 1654 | 0.120 |
Why?
|
| Telephone | 1 | 2017 | 617 | 0.120 |
Why?
|
| Medically Uninsured | 1 | 2019 | 853 | 0.120 |
Why?
|
| Tongue Neoplasms | 1 | 2015 | 180 | 0.120 |
Why?
|
| Outpatients | 1 | 2021 | 1486 | 0.120 |
Why?
|
| Lymphatic Metastasis | 2 | 2019 | 2924 | 0.120 |
Why?
|
| Insurance, Health | 3 | 2022 | 2494 | 0.110 |
Why?
|
| Ear Diseases | 1 | 2015 | 170 | 0.110 |
Why?
|
| Hospitals, Teaching | 1 | 2018 | 1179 | 0.110 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2017 | 430 | 0.110 |
Why?
|
| Infant | 10 | 2020 | 35136 | 0.110 |
Why?
|
| Forecasting | 2 | 2020 | 2951 | 0.110 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2013 | 140 | 0.110 |
Why?
|
| Stethoscopes | 1 | 2012 | 28 | 0.100 |
Why?
|
| Prognosis | 5 | 2023 | 29063 | 0.100 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2014 | 234 | 0.100 |
Why?
|
| Blood Transfusion | 1 | 2018 | 1301 | 0.100 |
Why?
|
| Acute Disease | 3 | 2018 | 7149 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2021 | 9239 | 0.100 |
Why?
|
| Neoplasm Staging | 5 | 2020 | 11031 | 0.100 |
Why?
|
| Hearing Loss | 1 | 2019 | 765 | 0.100 |
Why?
|
| Disability Evaluation | 1 | 2019 | 1827 | 0.100 |
Why?
|
| Bibliometrics | 1 | 2015 | 339 | 0.100 |
Why?
|
| Accreditation | 1 | 2014 | 450 | 0.100 |
Why?
|
| Rhabdoid Tumor | 1 | 2013 | 212 | 0.100 |
Why?
|
| Costs and Cost Analysis | 3 | 2023 | 1681 | 0.100 |
Why?
|
| Coculture Techniques | 1 | 2014 | 1341 | 0.090 |
Why?
|
| Ophthalmology | 1 | 2017 | 508 | 0.090 |
Why?
|
| Models, Organizational | 1 | 2014 | 574 | 0.090 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 2728 | 0.090 |
Why?
|
| Arteries | 1 | 2015 | 1119 | 0.090 |
Why?
|
| Risk Assessment | 6 | 2019 | 23338 | 0.090 |
Why?
|
| ROC Curve | 1 | 2018 | 3527 | 0.090 |
Why?
|
| Ependymoma | 1 | 2013 | 334 | 0.090 |
Why?
|
| Needs Assessment | 1 | 2016 | 1147 | 0.090 |
Why?
|
| Lower Extremity | 1 | 2018 | 1158 | 0.090 |
Why?
|
| Teratoma | 1 | 2013 | 395 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 3 | 2020 | 5391 | 0.090 |
Why?
|
| Disinfection | 1 | 2012 | 191 | 0.090 |
Why?
|
| Multiple Organ Failure | 1 | 2012 | 390 | 0.090 |
Why?
|
| Deglutition Disorders | 1 | 2015 | 605 | 0.090 |
Why?
|
| Patient Preference | 1 | 2017 | 890 | 0.090 |
Why?
|
| Memory | 1 | 2019 | 2174 | 0.090 |
Why?
|
| Radiotherapy, Conformal | 1 | 2013 | 548 | 0.090 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 1584 | 0.090 |
Why?
|
| Registries | 3 | 2020 | 8089 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 2 | 2014 | 3616 | 0.090 |
Why?
|
| Ischemia | 1 | 2018 | 1907 | 0.080 |
Why?
|
| Survivors | 1 | 2019 | 2291 | 0.080 |
Why?
|
| Ulnar Nerve | 1 | 1989 | 106 | 0.080 |
Why?
|
| Health Services Needs and Demand | 1 | 2017 | 1411 | 0.080 |
Why?
|
| Urination Disorders | 1 | 1989 | 241 | 0.080 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 1540 | 0.080 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 7785 | 0.080 |
Why?
|
| Cerebellar Neoplasms | 1 | 2013 | 587 | 0.080 |
Why?
|
| Diffusion of Innovation | 1 | 2013 | 725 | 0.080 |
Why?
|
| Brain Concussion | 1 | 2019 | 1320 | 0.080 |
Why?
|
| Reflex | 1 | 1989 | 365 | 0.080 |
Why?
|
| Publishing | 1 | 2015 | 833 | 0.080 |
Why?
|
| Medulloblastoma | 1 | 2013 | 683 | 0.080 |
Why?
|
| Disease-Free Survival | 4 | 2021 | 6895 | 0.080 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2013 | 1770 | 0.080 |
Why?
|
| Motor Neurons | 2 | 1989 | 844 | 0.080 |
Why?
|
| Self Report | 1 | 2018 | 3558 | 0.080 |
Why?
|
| Linear Models | 2 | 2019 | 5952 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2016 | 6365 | 0.080 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2012 | 1094 | 0.080 |
Why?
|
| Peripheral Arterial Disease | 1 | 2018 | 1188 | 0.070 |
Why?
|
| Brachial Plexus | 1 | 1989 | 163 | 0.070 |
Why?
|
| Carcinoma, Papillary | 1 | 2012 | 783 | 0.070 |
Why?
|
| Patient Admission | 1 | 2015 | 1380 | 0.070 |
Why?
|
| Venous Thrombosis | 1 | 2016 | 1239 | 0.070 |
Why?
|
| Thyroidectomy | 1 | 2012 | 879 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 11524 | 0.070 |
Why?
|
| Graft Survival | 2 | 2014 | 3737 | 0.070 |
Why?
|
| Medicaid | 1 | 2020 | 2736 | 0.070 |
Why?
|
| Survival Rate | 3 | 2019 | 12788 | 0.070 |
Why?
|
| Tissue and Organ Procurement | 1 | 2014 | 896 | 0.070 |
Why?
|
| Propensity Score | 1 | 2013 | 1781 | 0.070 |
Why?
|
| Thyroid Gland | 1 | 2012 | 1173 | 0.070 |
Why?
|
| Patient Selection | 2 | 2014 | 4215 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2018 | 9146 | 0.060 |
Why?
|
| Hospital Mortality | 1 | 2019 | 5317 | 0.060 |
Why?
|
| Age Factors | 2 | 2018 | 18370 | 0.060 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2013 | 895 | 0.060 |
Why?
|
| Telemedicine | 1 | 2022 | 2872 | 0.060 |
Why?
|
| Health Surveys | 1 | 2014 | 4037 | 0.060 |
Why?
|
| Databases, Factual | 4 | 2019 | 7729 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 13989 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14722 | 0.060 |
Why?
|
| Quality Indicators, Health Care | 1 | 2013 | 1831 | 0.050 |
Why?
|
| Cross Infection | 1 | 2012 | 1416 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 5137 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 39050 | 0.050 |
Why?
|
| Students, Medical | 1 | 2014 | 1862 | 0.050 |
Why?
|
| Length of Stay | 3 | 2020 | 6309 | 0.050 |
Why?
|
| Morbidity | 2 | 2019 | 1769 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 15540 | 0.050 |
Why?
|
| Graft Rejection | 1 | 2014 | 4397 | 0.050 |
Why?
|
| Curriculum | 1 | 2014 | 3605 | 0.050 |
Why?
|
| Negotiating | 1 | 2022 | 133 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2013 | 9849 | 0.050 |
Why?
|
| Leuprolide | 1 | 2022 | 321 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2018 | 21746 | 0.050 |
Why?
|
| Myoglobinuria | 1 | 1999 | 23 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 19905 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 11366 | 0.040 |
Why?
|
| Frozen Sections | 1 | 2020 | 155 | 0.040 |
Why?
|
| Electric Injuries | 1 | 1999 | 26 | 0.040 |
Why?
|
| Humidity | 1 | 2020 | 197 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2015 | 3309 | 0.040 |
Why?
|
| Infant, Newborn | 5 | 2020 | 25625 | 0.040 |
Why?
|
| Kidney Transplantation | 1 | 2014 | 4251 | 0.040 |
Why?
|
| Quality of Life | 2 | 2024 | 12804 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2014 | 4687 | 0.040 |
Why?
|
| Hospital Charges | 1 | 2020 | 362 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 3843 | 0.040 |
Why?
|
| Forearm | 1 | 2020 | 409 | 0.040 |
Why?
|
| Prevalence | 1 | 2014 | 15226 | 0.040 |
Why?
|
| Growth Disorders | 1 | 2022 | 645 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 12959 | 0.040 |
Why?
|
| Hematocrit | 1 | 2018 | 636 | 0.040 |
Why?
|
| Parotid Diseases | 1 | 2017 | 46 | 0.040 |
Why?
|
| Protons | 1 | 2022 | 1127 | 0.040 |
Why?
|
| Reoperation | 2 | 2018 | 4201 | 0.040 |
Why?
|
| Incidence | 3 | 2020 | 20947 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2023 | 2225 | 0.040 |
Why?
|
| Equipment Safety | 1 | 2017 | 264 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2018 | 528 | 0.030 |
Why?
|
| Risk Factors | 4 | 2017 | 72290 | 0.030 |
Why?
|
| Cost Savings | 1 | 2021 | 926 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2018 | 440 | 0.030 |
Why?
|
| Hospitals, Pediatric | 2 | 2017 | 1775 | 0.030 |
Why?
|
| Cause of Death | 2 | 2019 | 3584 | 0.030 |
Why?
|
| Limb Salvage | 1 | 2018 | 433 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2018 | 684 | 0.030 |
Why?
|
| Health Personnel | 2 | 2023 | 3218 | 0.030 |
Why?
|
| Neurons | 1 | 2014 | 9338 | 0.030 |
Why?
|
| Speech Intelligibility | 1 | 2015 | 81 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2023 | 2682 | 0.030 |
Why?
|
| Laminin | 1 | 1996 | 419 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2020 | 1354 | 0.030 |
Why?
|
| Electromyography | 2 | 1989 | 1379 | 0.030 |
Why?
|
| Pharynx | 1 | 2017 | 413 | 0.030 |
Why?
|
| Sex Factors | 2 | 2018 | 10397 | 0.030 |
Why?
|
| Muscular Dystrophies | 1 | 1996 | 393 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2018 | 1842 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 21683 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2018 | 10252 | 0.030 |
Why?
|
| Gastrostomy | 1 | 2015 | 309 | 0.030 |
Why?
|
| Duodenal Neoplasms | 1 | 2012 | 106 | 0.030 |
Why?
|
| Infratentorial Neoplasms | 1 | 2013 | 94 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 8863 | 0.030 |
Why?
|
| Drug Costs | 1 | 2020 | 1105 | 0.030 |
Why?
|
| Muscles | 1 | 1996 | 1614 | 0.020 |
Why?
|
| Organoplatinum Compounds | 1 | 2012 | 408 | 0.020 |
Why?
|
| Endocrine System Diseases | 1 | 2013 | 248 | 0.020 |
Why?
|
| Income | 1 | 2020 | 1913 | 0.020 |
Why?
|
| Leucovorin | 1 | 2012 | 628 | 0.020 |
Why?
|
| Triage | 1 | 2017 | 976 | 0.020 |
Why?
|
| Cranial Irradiation | 1 | 2013 | 401 | 0.020 |
Why?
|
| Nausea | 1 | 2012 | 673 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2015 | 2297 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2017 | 2453 | 0.020 |
Why?
|
| Vomiting | 1 | 2012 | 636 | 0.020 |
Why?
|
| Camptothecin | 1 | 2012 | 576 | 0.020 |
Why?
|
| Workload | 1 | 2015 | 850 | 0.020 |
Why?
|
| Age Distribution | 1 | 2015 | 2902 | 0.020 |
Why?
|
| Patients | 1 | 2015 | 900 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2020 | 2063 | 0.020 |
Why?
|
| Career Choice | 1 | 2014 | 744 | 0.020 |
Why?
|
| Poverty | 1 | 2020 | 2660 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2012 | 1619 | 0.020 |
Why?
|
| Neural Conduction | 1 | 1989 | 440 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2020 | 3313 | 0.020 |
Why?
|
| Educational Status | 1 | 2015 | 2540 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 1999 | 1972 | 0.020 |
Why?
|
| Body Height | 1 | 2013 | 1577 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2023 | 53288 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2013 | 2879 | 0.020 |
Why?
|
| Demyelinating Diseases | 1 | 1989 | 354 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2013 | 1357 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 20822 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 1989 | 602 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2014 | 2240 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 3479 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1989 | 685 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6538 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 168757 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 15076 | 0.010 |
Why?
|
| Action Potentials | 1 | 1989 | 1806 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 6993 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 12354 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2015 | 4468 | 0.010 |
Why?
|
| Compartment Syndromes | 1 | 1999 | 153 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 6364 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1996 | 694 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 40075 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 13695 | 0.010 |
Why?
|
| Heart Arrest | 1 | 1999 | 1470 | 0.010 |
Why?
|
| Burns | 1 | 1999 | 1815 | 0.000 |
Why?
|